Intel Ahead of Q3 Earnings: Analysts Expect EPS of $0.41 and 21% Revenue Growth
nashnova research
Intel reports Q3 earnings Thursday; analysts expect revenue of $16.5 billion, up 21% year-over-year, driven by data-center and AI demand. Whether the stock can rebound hinges on one thing — management raising full-year guidance.
How high is the bar Wall Street has set?
Consensus calls for adjusted EPS of $0.41, nearly double last year's $0.23.
Revenue is expected at $16.5 billion, up 21% year-over-year, led by data-center and AI business.
This means → the market has already priced in "growth." The real test is whether Intel can beat an already elevated bar.
What are the bulls and bears saying?
Bank of America's Vivek Arya keeps a Buy rating with a $145 target. He expects Intel to beat estimates and raise full-year guidance.
His thesis: CPU average selling prices keep rising, and the market increasingly sees CPUs as better suited to AI inference — actually running AI models, as opposed to training them — than GPUs. Intel benefits from both rising AI-server CPU demand and supply-chain improvements.
UBS's Timothy Arcuri is more cautious, holding a Neutral rating and cutting his target from $112 to $103. He calls revenue fundamentals "quite strong" but sees the valuation as full.
Is Intel worth buying here?
BULL
AI inference favors CPUs
CPUs outperform GPUs at inference tasks; Intel is the most direct beneficiary.
Upside to earnings
BofA expects a beat and a guidance raise; target $145.
BEAR
Valuation already full
UBS cut its target to $103, arguing the strong fundamentals are priced in.
Foundry still unproven
Progress on EMIB-T packaging and 14A process remains the key unknown.
In plain terms = bulls are betting the AI-inference tailwind has further to run; bears worry the good news is already in the stock. The debate isn't whether fundamentals are strong — it's whether they can get stronger.
Which technology milestones is the market watching?
UBS flags two technologies: EMIB-T chip packaging — an advanced method for connecting different chip modules together — and the 14A process node, Intel's next-generation manufacturing technology.
Both are central to whether Intel's foundry business — making chips for other companies — can compete with TSMC.
This means → any update on these two during the earnings call may move the stock more than the revenue number itself.
How far has the stock fallen, and what else is weighing on it?
Intel shares are down 32% from their June 22 all-time high, trading at $95.53, yet still up roughly 159% year-to-date.
Recent pressure came from Elon Musk, who hinted at talks with TSMC to take over the Terafab AI-chip joint venture, triggering a selloff.
Musk later referenced a "major potential breakthrough" in chip manufacturing. The Terafab project — a collaboration among Intel, Tesla, and SpaceX — remains a market focal point. This reflects a stock caught between two forces: underlying fundamentals and the uncertainty of external partnerships.
What is the single most important thing in this report?
One number matters above all: whether management raises full-year guidance.
In plain terms = the market already expects 21% revenue growth. If management says "the second half will be even better," the stock has a reason to rally. A mere "in-line" result probably won't be enough.
This earnings call is a direct window into two questions: how durable is AI-server CPU demand, and can the foundry business actually compete.
市场有风险，内容仅供研究参考，不构成投资建议。